Depomed Earns $10 Mln Milestone for FDA Approval of Mallinckrodt’s XARTEMIS XR – Stock Firmer
Depomed, Inc. (DEPO) gains Wednesday, getting a milestone payment after the FDA approved Mallinckrodt plc’s…
Browsing: DEPO
After-Hours: Depomed Gains 8% on Q4 Results, 2014 Guidance Beat
Depomed (DEPO) shares were up 8% after hours after it reported quarterly results that surpassed…